In developing countries, diarrhoeal diseases are one of the major causes of death in children under 5 years of age. It is known that diarrhoeagenic Escherichia coli (DEC) is an important aetiological agent of infantile diarrhoea in Nicaragua. However, there are no recent studies on antimicrobial resistance among intestinal E. coli isolates in Nicaraguan children. The aim of the present study was to determine the antimicrobial resistance pattern in a collection of 727 intestinal E. coli isolates from the faeces of children in Leó n, Nicaragua, between March 2005 and September 2006. All samples had been screened previously for the presence of DEC by multiplex PCR. Three hundred and ninety-five non-DEC isolates (270 from children with diarrhoea and 125 from children without diarrhoea) and 332 DEC isolates (241 from children with diarrhoea and 91 from children without diarrhoea) were analysed in this study. In general, antimicrobial resistance among the 727 intestinal E. coli isolates was high for ampicillin (60 %), trimethoprimsulfamethoxazole (64 %) and chloramphenicol (11 %). Among individual E. coli categories, enteroaggregative E. coli isolates from children with and without diarrhoea exhibited significantly higher levels of resistance (P,0.05) to ampicillin and trimethoprim-sulfamethoxazole compared to the other E. coli categories. Resistance to ceftazidime and/or ceftriaxone and a pattern of multiresistance was related to CTX-M-5-or CTX-M-15-producing E. coli isolates. The results suggest that E. coli isolates from Nicaraguan children have not reached the high levels of resistance to the most common antibiotics used for diarrhoea treatment as in other countries.
INTRODUCTION
In developing countries, diarrhoeal diseases are one of the major causes of death in children under 5 years of age (Boschi-Pinto et al., 2008; Bryce et al., 2005) . Since the disease is generally self-limiting, antimicrobial agents are not usually recommended for treatment of diarrhoea (Gadewar & Fasano, 2005) . However, there are some exceptions, i.e. to prevent diarrhoea in travellers (DuPont, 2005) , to shorten the course of the disease when the pathogen has been identified and to prevent transmission of the disease (Gadewar & Fasano, 2005; O'Ryan et al., 2005) .
Diarrhoeagenic Escherichia coli (DEC) strains are among the bacteria most frequently associated with diarrhoea in children from developing countries (O'Ryan et al., 2005; Thapar & Sanderson, 2004) . There are six pathotypes of DEC: enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC) or verocytotoxin-producing E. coli, enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (Kaper et al., 2004; Nataro & Kaper, 1998) . Reports of antibiotic resistance have increased steadily in DEC isolates affecting children and travellers (Djie-Maletz et al., 2008; Estrada-García et al., 2005; Mendez Arancibia et al., 2009; Nguyen et al., 2005; Ochoa et al., 2009; Vila et al., 2001) . Resistance to antibiotics such as ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole is found in DEC isolated from children with diarrhoea in developing countries where the overuse and misuse of antibiotics is common (Djie-Maletz et al., 2008; Nguyen et al., 2005) .
Resistance in commensal E. coli isolates in children is emerging (Bartoloni et al., 2006; Sepp et al., 2009) and it is well known that commensal bacteria are reservoirs for antimicrobial resistance genes in both the community and hospital settings (Alekshun & Levy, 2006) .
Information regarding the prevalence of antimicrobial resistance in pathogens can be used for selecting an optimal treatment when necessary (Okeke et al., 2005) . DEC remains an important aetiological agent of infantile diarrhoea in Nicaragua (Mayatepek et al., 1993; Paniagua et al., 1997; Vilchez et al., 2009 ). There are no recent studies regarding antimicrobial resistance among DEC and non-DEC isolates in Nicaraguan children.
The aim of the present study was to determine the antimicrobial resistance pattern of intestinal E. coli isolates with and without DEC virulence markers in children younger than 5 years of age with and without diarrhoea in Leó n, Nicaragua.
METHODS
E. coli isolates. In this study, the susceptibilities to different antimicrobial agents were investigated in 727 E. coli isolates identified in a previous study (Vilchez et al., 2009) . Three hundred and ninety-five isolates were non-DEC (270 from children with diarrhoea and 125 from children without diarrhoea) and 332 were DEC (241 from children with diarrhoea and 91 from children without diarrhoea). The distribution of the DEC isolates herein analysed was as follows: 203 EAEC isolates, 73 ETEC isolates, 47 EPEC isolates, 8 EHEC isolates and 1 EIEC isolate.
Antibiotics. The following antibiotics were tested: ampicillin (AstraZeneca), amoxicillin-clavulanic acid (Sigma and SmithKline Beecham), ceftazidime (Sigma), ceftriaxone (Sigma), ciprofloxacin (Sigma), chloramphenicol (Sigma), gentamicin (Sigma), imipenem (Merck) and trimethoprim-sulfamethoxazole (Sigma).
Antibiotic susceptibility testing. MICs were determined by the agar dilution method according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2006) . E. coli ATCC 25922 and Enterococcus faecalis ATCC 29212 were used as control strains. The antibiotic susceptibility testing data were analysed using WHONET 5.4 and SPSS 17.0 software. In addition, the data were analysed using the Kruskal-Wallis H test for multiple comparison and the MannWhitney U test for comparing two groups of E. coli in terms of antibiotic resistance to each of the tested antimicrobial agents. A Pvalue of ,0.05 was considered significant.
Phenotypic detection of extended-spectrum b-lactamases (ESBLs). ESBL production in the E. coli isolates that showed resistance to any of the third-generation cephalosporins tested (cefotaxime, ceftriaxone and ceftazidime) was analysed using the Etest system (bioMérieux), cefotaxime/cefotaxime+clavulanic acid, ceftazidime/ ceftazidime+clavulanic acid, and cefepime/cefepime+clavulanic acid.
PCR amplification for detection of b-lactamase genes and sequencing analysis. E. coli isolates resistant to at least two antibiotics including one b-lactam were screened for the resistance genes encoding SHV, TEM, CTX-M and OXA enzymes by a multiplex PCR assay using universal primers following the procedure described by Fang et al. (2008) . Further detection of CTX-M groups 1, 2, 9, 8 and 25 in the E. coli isolates positive for CTX-M was performed using a multiplex PCR assay as described by Dallenne et al. (2010) and a single PCR assay as described by Pitout et al. (2004) . PCR amplification was carried out on a GeneAmp PCR system 9700 (Applied Biosystems Division) thermal cycler.
DNA sequencing analysis was performed in E. coli isolates that were positive for ESBL production with the Etest system. For TEM and OXA enzymes, sequencing primers described by Fang et al. (2008) were used, and for CTX-M enzymes, sequencing primers described by Pitout et al. (2004) were used. Amplified PCR products were purified using a QIAquick PCR Purification kit (Qiagen) and bidirectional sequencing was performed. Each sequence was then compared with known b-lactamase gene sequences (http://www.lahey.org/Studies/) by multiple-sequence alignment using the BLAST program.
Typing of E. coli isolates producing ESBLs by randomly amplified polymorphic DNA (RAPD) analysis. The epidemiological relationships between E. coli isolates producing ESBL were analysed intra sample and among the samples by RAPD as described by Touati et al. (2007) with some modifications. Total DNA was prepared with a QIAamp DNA mini kit (Qiagen) and used for RAPD typing, which was performed using PuReTaq Ready-To-Go PCR beads (GE Healthcare) together with primer 4 (59-AAGAGCCCGT-39) and primer 5 (59-AACGCGCAAC-39) (Thermo Fisher Scientific). PCR amplification was carried out as follows: 1 cycle at 94 uC for 5 min, 35 (primer 4) and 31 (primer 5) cycles at 94 uC for 5 s, 42 uC for 30 s and 72 uC for 1 min, with a final extension period at 72 uC for 5 min. After amplification, the banding pattern of randomly amplified DNA was visualized and analysed on a 1.5 % agarose gel in Tris/acetate buffer. A negative control was included in each PCR run with no target DNA. Reproducibility of the amplification results was evaluated in parallel experiments by the repetition of the PCRs three times. Electrophoresed agarose gels were analysed using BioNumerics version 6 software (Applied Maths). Dendrograms based on the Jaccard coefficient and unweighted pair group method using arithmetic averages were generated.
RESULTS AND DISCUSSION
Antibiotic susceptibilities in the E. coli isolates To the best of our knowledge, there are no studies in Latin America that have included antibiotic resistance analysis in both DEC and non-DEC from children with and without diarrhoea. However, there are a few studies that have investigated antibiotic resistance only in E. coli isolates positive for a DEC virulence marker (Estrada-García et al., 2005; Ochoa et al., 2009) or only in non-DEC (Bartoloni et al., 2006; Pallecchi et al., 2004 Pallecchi et al., , 2007 . The results of the antibiotic susceptibility testing performed on 727 E. coli isolates (Table 1) showed that resistance to ampicillin was found in 67.7 % (225/332) of the DEC isolates and in 53.2 % (210/395) of the non-DEC isolates, and resistance to trimethoprim-sulfamethoxazole was found in 71.6 % (238/332) of the DEC isolates and 57.7 % (228/395) of the non-DEC isolates. Furthermore, resistance to chloramphenicol was found in 9.3 % (31/332) of the DEC isolates and in 13 % (51/395) of the non-DEC isolates. No resistance to imipenem was observed, and for the other agents the level of resistance was low in all E. coli isolates (¡2.6 %).
Differences in the distributions of resistance and MICs were seen for individual antibiotics and for each category of E. coli strains. The multiple comparisons showed a significant difference in resistance to amoxicillin-clavulanic acid (P50.031), ampicillin (P,0.001) and trimethoprimsulfamethoxazole (P,0.001).
When comparisons of the antibiotic resistance levels of two groups of E. coli strains were performed, it was found that the group of EAEC from children with diarrhoea showed the major number of differences in term of resistance to most of the tested antibiotics when compared to other E. coli categories isolated from children with and without diarrhoea. For example, this group of E. coli strains was significantly more resistant (P,0.005) than EHEC and EPEC to ampicillin and trimethoprim-sulfamethoxazole. Interestingly, EAEC from children without diarrhoea was also significantly more resistant (P,0.005) than non-DEC from children with and without diarrhoea to amoxicillinclavulanic acid, ampicillin and trimethoprim-sulfamethoxazole. In addition, EAEC was significantly more resistant (P50.021) than ETEC from children with diarrhoea to amoxicillin (more information about the level of resistance in the other E. coli group can be found in Supplementary  Table S1 of JMM Online). Other studies carried out in DEC have also shown that EAEC possesses higher levels of antibiotic resistance than other E. coli groups. For example, Estrada-García et al. (2005) found in a study carried out in Mexican children that among all of the DEC categories, EAEC was significantly more resistant than EPEC to ampicillin and trimethoprim-sulfamethoxazole. In a recently published study carried out in Peru, the prevalence of resistance to ampicillin, cotrimoxazole, tetracycline and nalidixic acid was significantly higher (P,0.05) in EAEC than in EPEC and ETEC (Ochoa et al., 2009) . The authors hypothesized that the higher resistance levels in EAEC compared to other groups of DEC could be due to frequent use of antibiotics since these diarrhoeagenic pathotypes often cause persistent diarrhoea and/or are present in asymptomatic carriers. This hypothesis is supported by the findings by Vilchez et al. (2009) , who showed that EAEC was the most frequently isolated pathotype of E. coli, with a high level of asymptomatic carriers. Our data clearly show that, at least in Latin America, EAEC isolated from children possesses high levels of resistance to ampicillin and trimethoprim and could become a serious health problem.
Different resistance patterns were defined in all E. coli isolates with and without diarrhoeagenic virulence markers. The two most prevalent multi-resistance patterns (resistance to at least two antibiotics) among the 727 E. coli isolates included in this study were (i) ampicillin and trimethoprim-sulfamethoxazole (41 %) and (ii) ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole (7.2 %). Antimicrobial res- istance patterns in E. coli isolates differ among countries. In Peru, Ochoa et al. (2009) reported multi-resistance to ampicillin and trimethoprim-sulfamethoxazole as the second most common pattern in DEC, whereas in Vietnam, Nguyen et al. (2005) reported that ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole was the most common resistance pattern among DEC.
Although amoxicillin-clavulanic acid, ceftazidime, gentamicin, ceftriaxone and imipenem are not indicated to treat diarrhoea in children, we tested the susceptibilities to these antibiotics in all isolates, since they could be empirically or incidentally used. A recent publication showed that outpatients with diarrhoea of presumed bacterial origin at the emergency department of the University Hospital of Leó n, Nicaragua (50 % being children ,6 years of age), received trimethoprim-sulfamethoxazole (18.5 %) and ciprofloxacin (8.5 %) to shorten the course of the disease (den Engelsen et al., 2009). As shown above, some EAEC and non-DEC isolates from children with/without diarrhoea show low level of resistance to amoxicillin-clavulanic acid, ceftazidime and/or ceftriaxone and ciprofloxacin.
Resistance to ceftazidime and/or ceftriaxone was related to ESBL production and a pattern of multi-resistance (ampicillin, chloramphenicol, ceftazidime and/or ceftriaxone, gentamicin and ciprofloxacin) was observed in those E. coli isolates, whereas resistance to amoxicillin-clavulanic acid could be due to presence of other enzymes such as AmpC (Denton, 2007) . Contrary to our results, the studies carried out in Peru and Mexico showed that DEC was sensitive to ceftazidime and/or to ceftriaxone (EstradaGarcía et al., 2005; Ochoa et al., 2009 ).
Detection of b-lactamase genes and sequencing analysis
The results from the detection of E. coli isolates harbouring genes encoding SHV, TEM, CTX-M and OXA enzymes are shown in Table 2 . The gene encoding TEM enzyme was detected in most isolates, with a higher prevalence in EAEC isolates from children with diarrhoea (12.7 %) and in non-DEC from children without diarrhoea (13 %). The gene CTX-M was more commonly detected in EAEC (4.3 %) and in non-DEC from children without diarrhoea (5.6 %). Among the isolates harbouring the CTX-M gene, 13/13 were resistant to ampicillin, 13/13 to ceftazidime, 10/13 to chloramphenicol, 13/13 to ceftriaxone, 5/13 to ciprofloxacin, 8/13 to gentamicin and 13/13 to trimethoprimsulfamethoxazole. The gene encoding OXA enzyme was detected in EAEC isolates from children with diarrhoea and in non-DEC from children with/without diarrhoea ( Table  2 ). None of the E. coli isolates harboured the gene encoding SHV enzyme.
The E. coli isolates positive for ESBLs were selected for sequencing. All were positive in the PCR for CTX-M and TEM, and 1/13 was positive for OXA enzyme. The multiplex PCR for detection of CTX-M-1, 2, 9, 8 and 25 showed that 2/13 E. coli isolates were positive for the CTX-M-2 group and 11/13 were positive for the CTX-M-1 group. After sequencing, it was found that TEM-1 and OXA-1/-30 were present in the E. coli isolates positive in the PCR assay for TEM or OXA enzymes. For the CTX-M groups, CTX-M-5 was found as the specific enzyme in 2/13 E. coli (one EAEC and one non-DEC) isolates positive for the CTX-M-2 group and CTX-M-15 was found as the specific enzyme in 11/13 E. coli (four EAEC and seven non-DEC) isolates positive for the CTX-M-1 group.
The CTX-M group of enzymes has become one of the main public health concerns due to their ability to be present in bacteria causing both nosocomial and communityacquired infections. E. coli is most often responsible for producing CTX-M b-lactamases and seems to be a true community ESBL pathogen (Pitout & Laupland, 2008) . The prevalence of CTX-M enzymes in Latin American (13) 3 (23) ETECD (9) 4 (44) 1 (11) 1 (11) Non-DECD (125) 26 (20) 12 (9.6) 16 (13) 7 (5.6) 1 (0.8) 7 (5.6) *Children with diarrhoea. DChildren without diarrhoea.
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countries is among the highest in the world (Villegas et al., 2008) with CTX-M-1 and -2 groups among the most commonly detected. The production of CTX-M-2, -9, -14, -15, -24 and -56 has been reported in non-DEC strains from healthy children (Pallecchi et al., 2004 (Pallecchi et al., , 2007 , whereas such findings have not been shown for DEC. Our study showed the production of CTX-M-2 and CTX-M-15 in DEC and non-DEC strains from children with and without diarrhoea. b-Lactamase enzymes are the main mechanism of resistance to b-lactam antibiotics in members of the Enterobacteriaceae (Paterson, 2006; Torres et al., 2007) . Currently, the most widely distributed CTX-M enzyme on a worldwide basis is CTX-M-15, which was first detected in E. coli isolated from India during 2001. CTX-M-15 has often been associated with the co-production of other blactamases such as TEM-1 and OXA-1 (Peirano & Pitout, 2010; Pitout, 2010) . Our results are in accordance with that information, i.e. the production of CTX-M-15 together with the co-production of TEM-1 and OXA-1/-30 was found in our study. It is clear that ESBLs have emerged in EAEC and non-DEC from Nicaraguan children with and without diarrhoea.
Typing of ESBL-producing E. coli isolates by RAPD analysis
Thirteen E. coli isolates producing ESBLs were selected for RAPD analysis. The analysis revealed that these E. coli isolates could be separated into five clones (Fig. 1) . Among these clones, D1 encompassed all of the EAEC isolates (three of three E. coli isolates) and clone D4 most of the non-DEC isolates (four of seven E. coli isolates) from children without diarrhoea. In addition, these isolates harboured the enzyme CTX-M-15. Interestingly, clone D5 contained one EAEC and one non-DEC producing CTX-M-5 from children with diarrhoea, which could indicate the transfer of resistance genes from non-pathogenic to pathogenic bacteria.
The problems of antimicrobial resistance require appropriate interventions with special regard to multi-resistant Gram-negative pathogens (Gould, 2008 (Gould, , 2009 ). The rate of resistance to the most common antibiotics used for diarrhoea treatment is increasing in Latin America. In E. coli isolates, the resistance is seen in both pathogenic and non-pathogenic isolates (Estrada-García et al., 2005; Fig. 1 . Clonal similarity of E. coli producing ESBLs. EAECa, enteroaggregative E. coli from children with diarrhoea; EAECb, enteroaggregative E. coli from children without diarrhoea; non-DECa, non-diarrhoeagenic E. coli from children with diarrhoea; non-DECb, nondiarrhoeagenic E. coli from children without diarrhoea. Mayatepek et al., 1993; Ochoa et al., 2009; Pallecchi et al., 2004 Pallecchi et al., , 2007 . Finally, the antibiotic resistance level in E. coli from children with/without diarrhoea has not yet reached the high levels of resistance to the most common antibiotics used for diarrhoea treatment as in other countries. However, CTX-M-5 or CTX-M-15 production was detected in some multi-antibiotic-resistant DEC and non-DEC clones, which suggests the emergence of ESBLs in the Nicaraguan community, and this may indicate future treatment complications.
